This trial investigated the potential of Nanoscope Therapeutics' MCO-010 to restore vision in patients with retinitis ...

As a companion diagnostic, Oncomine will be used to identify patients eligible for treatment with Servier’s Voranigo.

In an exclusive interview, the CEO of ImmunoPrecise Antibodies described the benefits of rabbit monoclonal antibodies in ...

A stake by France-owned Bpifrance and promise of local job retention have allayed political backlash over the sale of ...

FibroBiologics has entered a master services agreement with Charles River Laboratories to develop and manufacture cell-based ...

Astellas Pharma has received approval from the FDA for VYLOY in conjunction with chemotherapy, for the treatment of advanced ...

Arcutis Canada, has received Health Canada's approval for ZORYVE to treat seborrheic dermatitis in patients aged nine years ...

A partial hold was placed on the trial after results showed variance between squamous and non-squamous NSCLC patient ...

While adverse events (AEs) were reported for 97% of trial participants, such cases were predominantly mild to moderate.

An 800% increase in licensing deal values indicates growing confidence in mRNA technology, but some vaccine producers are ...

The US FDA has approved AbbVie's VYALEV to treat motor fluctuations in adults with advanced Parkinson's disease (PD).